Independent event adjudication has the power to enhance the scientific validity of cardiovascular trials by allowing consistent assessment of cardiovascular events and employing standardized definitions across trial sites.
May 04, 2021
The COVID-19 pandemic has significantly impacted the ability of clinical researchers to collect data assessing cardiovascular events. Because the SARS-CoV-2 virus is commonly associated with cardiovascular risk, patients may be more reluctant to seek medical attention, resulting in underreporting of cardiovascular events and therefore reduced safety of cardiovascular trials. As such, the industry has increasingly acknowledged the value of digital devices and other methods for remote data capture.
Independent event adjudication has the power to enhance the scientific validity of cardiovascular trials by allowing consistent assessment of cardiovascular events and employing standardized definitions across trial sites. The ability to virtualize processes is study specific and the experience gained during the pandemic will have a lasting effect on future cardiovascular trial design and conduct.
In this webinar, our expert panel will discuss:
Best practices for cardiovascular event adjudication
- How to employ standardized definitions across trial sites
- Recent advances in the selection and application of connected devices
- Long term effects of the COVID-19 pandemic on cardiovascular trial design
Join C. Michael Gibson, MS, MD, CEO, Baim and PERFUSE research institutes at Harvard Medical School and experts from ICON plc, Jack Martin, MD, FACC, Senior Director, Cardiovascular Therapeutics, Drug Development Services; Craig McLendon, RN, CCRN, Sr. Dir Adjudication & DMC Mgmt., Clinical Research Services; and Deirdre Albertson, Vice President, Project Management, Cardiovascular, Metabolic and Women’s Health, for the live webinar on Friday, May 21, 2021 at 11am EDT (4pm BST/UK).
For more information, or to register for this event, visit cardiovascular event adjudication during COVID-19 and beyond.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
Share article on social media or email: